Thai court grants Japanese man custody of 13 surrogate children


Earlier this month BioEdge reported on a court case involving a 28-year-old Japanese man, Mitsutoki Shigeta, who is believed to have fathered 15 children via surrogacy in Thailand. Authorities had taken Shigeta’s children into custody after concerns were raised about their welfare.

Since then, the court has returned custody of 13 of the children to Shigeta, saying that he  demonstrated that he is financially stable and had showed his plans to care for the children. The court said he had a right to custody because the children were born before the introduction of a new law prohibiting commercial surrogacy, and because the surrogate mothers signed documents waiving their custody rights.

Shigeta is the son of Japanese tycoon Yasumitsu Shigeta, founder and chief executive officer of the Japanese communications and technology company Hikari Tsushin. He earns approximately earns over 100 million baht ($3.1 million) in annual dividends, according to a statement released by the court.

Shigeta, who has kept an extremely low profile, did not attend the court’s sessions. A Thai lawyer represented him.

Shigeta told the court via video-link that he wanted to have a large family with which he could share his sizeable inheritance.

Others have offered a different story. Mariam Kukunashvili, founder of the New Light clinic that recruited some of the surrogate mothers, said Shigeta told her “he wanted to win elections and could use his big family for voting”.

“He said he wanted 10 to 15 babies a year, and that he wanted to continue the baby-making process until he’s dead,” Kukunashvili told the Associated Press in 2014.  

Sam Everingham, global director of the charity Families Through Surrogacy, said that the case was extraordinary and worrying. “It does cast surrogacy in a bad light when agencies or parents can get away with having this many children in one country”. 




MORE ON THESE TOPICS | commercial surrogacy, japan, law, surrogacy, thailand

This article is published by Xavier Symons and BioEdge under a Creative Commons licence. You may republish it or translate it free of charge with attribution for non-commercial purposes following these guidelines. If you teach at a university we ask that your department make a donation. Commercial media must contact us for permission and fees. Some articles on this site are published under different terms.

 
 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

 
comments powered by Disqus